Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

BACKGROUND: Asymmetric dimethylarginine (ADMA)––the most potent endogenous NO-synthase inhibitor, has been regarded as mediator of endothelial dysfunction and oxidative stress. Considering experimental data, levels of ADMA and its structural isomer symmetric dimethylarginine (SDMA) might be elevated...

Descripción completa

Detalles Bibliográficos
Autores principales: Worthmann, Hans, Li, Na, Martens-Lobenhoffer, Jens, Dirks, Meike, Schuppner, Ramona, Lichtinghagen, Ralf, Kielstein, Jan T., Raab, Peter, Lanfermann, Heinrich, Bode-Böger, Stefanie M., Weissenborn, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729507/
https://www.ncbi.nlm.nih.gov/pubmed/29237474
http://dx.doi.org/10.1186/s12974-017-1016-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729507/
https://www.ncbi.nlm.nih.gov/pubmed/29237474
http://dx.doi.org/10.1186/s12974-017-1016-1

Ejemplares similares